T. Rowe Price Investment Management, Inc. - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,386
-39.5%
1,610,4960.0%0.02%
-36.0%
Q2 2023$37,026
-36.5%
1,610,496
-18.2%
0.02%
-40.5%
Q1 2023$58,318
+19.5%
1,968,175
+0.6%
0.04%
+13.5%
Q4 2022$48,822
-99.9%
1,955,977
-2.0%
0.04%
+5.7%
Q3 2022$43,465,0001,996,5290.04%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 5,984,736$149,379,01117.99%
Aquilo Capital Management, LLC 629,411$15,710,0995.90%
BVF INC/IL 4,692,604$117,127,3964.94%
Artal Group S.A. 2,000,000$49,9202.79%
Redmile Group, LLC 2,673,837$66,738,9722.73%
Avoro Capital Advisors LLC 3,850,000$96,096,0001.44%
Deer Management Co. LLC 615,895$15,372,7391.42%
AtonRa Partners 27,125$677,0400.86%
Rock Springs Capital Management LP 1,227,779$30,645,3640.74%
EcoR1 Capital, LLC 796,093$19,870,4810.60%
View complete list of KYMERA THERAPEUTICS INC shareholders